EGLN3 Antikörper
-
- Target Alle EGLN3 Antikörper anzeigen
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EGLN3 Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human EGLN3 (NP_071356.1).
- Isotyp
- IgG
- Top Product
- Discover our top product EGLN3 Primärantikörper
-
-
- Applikationshinweise
- IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
- Andere Bezeichnung
- EGLN3 (EGLN3 Produkte)
- Hintergrund
- EGLN3 (Egl-9 Family Hypoxia Inducible Factor 3) is a Protein Coding gene. Diseases associated with EGLN3 include Hypoxia and Erythrocytosis, Familial, 2, Autosomal Recessive. Among its related pathways are ErbB signaling pathway and Cellular Senescence (REACTOME). Gene Ontology (GO) annotations related to this gene include oxidoreductase activity and oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen. An important paralog of this gene is EGLN1.
- Gen-ID
- 112399
- UniProt
- Q9H6Z9
- Pathways
- Positive Regulation of Endopeptidase Activity
-